Madden Center for Value Creation: Entrepreneurship & Longevity Conference
Save the Date: March 24, 2023
Connect with innovators, pharmaceutical and biotechnology executives, investors, and regulatory experts from the FDA in a series of roundtables and open-ended discussions with the aim of fostering an innovation ecosystem and the next generation of precision medicine and longevity.
Sponsored by the FAU Madden Center for Value Creation and FAU Health.
Contact Tracy Kidwell (email@example.com) for more info.
Bob Langer (Keynote), David H. Koch Institute Professor, Massachusetts Institute of Technology, Co-Founder of Moderna
Diane Abbitt, Attorney, Start-Ups and Biotech
Omar Abudayyeh, McGovern Institute Fellow at Massachusetts Institute of Technology, Co-Principal Investigator of the Abudayyeh Gootenberg Lab, Co-Founder, Sherlock Biosciences, Co-Inventor, CRISPR
Janice Chen, Co-Founder & CTO, Mammoth Biosciences
Nathan Cheng, Executive Director, Longevity Biotech at On Deck
Allison Duettman, CEO, Foresight Institute
Chandra Duggirala, Co-Founder, CEO at FounderPool
Amanda Elam, CEO & Co-Founder, Galaxy Diagnostics
Leonardo Ferreira, Assistant Professor at Medical University of South Carolina, Post-Doc, Bluestone Lab, University of California - San Francisco
Agustin Fernandez III, CEO, Rational Vaccines
Jonathan Gootenberg, McGovern Institute Fellow at Massachusetts Institute of Technology, Co-Principal Investigator of the Abudayyeh Gootenberg Lab, Co-Founder, Sherlock Biosciences, Co-Inventor, CRISPR
Eric Hargan, Former Deputy Secretary - HHS, Founder & CEO of The Hargan Group
Bryan Johnson, Founder & CEO of Blueprint
Geoffrey Ling, Founding Director, DARPA Biological Technologies Office, CEO, On Demand Pharmaceuticals, Inc.
Jeff Madden, CEO, ADvantage Therapeutics, Inc., Former RMB Capital, Former Partner - Iron Bridge Capital Management
Jim O'Neill, Co-founder, the Thiel Fellowship, Former HHS Official
James Peyer, CEO, Cambrian Bio
Walter Schmidt, Director, mRNA Division, ADvantage Therapeutics
Richard Serbin, Former Global Head of Corporate Development for Johnson & Johnson, Regulation and Patent Attorney, Pharmacist
Alfred Slanetz, President & CEO, Geneius Biotechnology, Inc.
Siri Terjesen, Phil Smith Professor, Associate Dean of Research & External Relations, Executive Director, Madden Center for Value Creation at Florida Atlantic University
Andre Watson, Chairman & CEO, Ligandal, Biomaterials Scientist and Nanoengineer, Forbes 30Under30 Healthcare 2021